Data vignettes for the application of response surface models in drug combination analysis

Area of Science:

• Pharmacology
• Computational Biology
• Data Science

Background:

• Drug combination analysis is crucial for developing effective cancer therapies.
• Response surface models (RSMs) are increasingly used but require robust validation.
• Evaluating the utility of various interaction metrics is essential for accurate analysis.

Purpose of the Study:

• To provide a comprehensive dataset for evaluating the robustness and utility of response surface models in drug combination analysis.
• To facilitate the comparison of traditional index methods with advanced interaction metrics.
• To enable replication and application of drug combination analyses on new datasets.

Main Methods:

• Utilized simulated experimental data for traditional index method evaluation.
• Processed a library of interaction metrics on the Merck OncoPolyPharmacology Screen.
• Developed and applied scripts for metric implementation and performance evaluation against mechanistic classifications.
• Included data and scripts from published and unpublished drug combination experiments.

Main Results:

• The dataset enables rigorous assessment of different drug interaction analysis approaches.
• Provides a benchmark for comparing the performance of various computational metrics.
• Facilitates the validation of response surface models using diverse experimental data.

Conclusions:

• The dataset enhances the reliability and reproducibility of drug combination studies.
• Supports the advancement of accurate and efficient methods for analyzing drug interactions.
• Promotes wider adoption and validation of computational tools in pharmacological research.